In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cardinal and Allegiance merge in $5.2bn deal

Executive Summary

Cardinal Health will acquire Allegiance (hospital products supplier) for $5.2bn. Cardinal will issue about $4.3bn in stock--49mm shares total, or 0.415 share for each of Allegiance's 118.4mm outstanding shares. Cardinal also assumes $890mm in debt.
Deal Industry
  • Distributors
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies